April 7, 2016
Health insurers who deny patients access to hepatitis C cures could be violating federal law, explains an April 5 letter from the Alliance for Patient Access and The AIDS Institute to Florida’s insurance commissioner.
April 6, 2016
The Food and Drug Administration approved the second U.S. biosimilar on Tuesday, clearing the drug for seven different indications.
April 4, 2016
The Food and Drug Administration has released its long-anticipated draft guidance on biosimilar labeling – but the document may leave some health care providers and patient advocates disappointed.
March 29, 2016
Two months have passed since the World Health Organization released its final proposal on naming biological and biosimilar medications.
March 23, 2016
Many pregnant women embrace eating habits that protect and benefit their unborn babies. But their choices can become complicated when claims from unscientific sources clash with regulatory agencies’ clear, established nutrition guidance.
March 17, 2016
Following a lengthy and controversial process, the Centers for Disease Control and Prevention issued new guidelines Tuesday on prescribing opioids for pain.
March 15, 2016
The Centers for Medicare and Medicaid Services’ newly proposed rule may reinvent how medications are paid for under Part B, which covers infused or injected medications administered in a clinic or hospital setting.
March 10, 2016
The Food and Drug Administration is on a mission: Make 2016 the year of diversity in clinical trials.
February 26, 2016
A recommendation from the U.S. Preventive Services Task Force is bringing new attention to postpartum depression and its treatment.
February 18, 2016
Patients who battle both hepatitis C and a health plan that denies coverage for the cure have a new recourse: legal action.
